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Foxp3+Regulatory T cells (Tregs) are pivotal for the maintenance of tolerance. Alterations
in their number and/or function have been proposed to occur in the autoimmune-prone
non-obese diabetic (NOD) mouse. Comparing the frequencies and absolute numbers of
CD4+Foxp3+CD25+ Tregs among 4 to 6-week old NOD, B6, and BALB/c mice, we
observed differences in counts and Foxp3 expression in Tregs from secondary lymphoid
organs, but not in the thymus. Upon TCR and IL-2 stimulation, NOD Tregs showed lower
responses than Tregs from B6 and BALB/c mice. Indeed, NOD Tregs responded with
less proliferation and with smaller increments in the expression of CD25, LAP-1, CD39,
PD-1, PD-L1, and LAG-3, when in vitro cultured for 3 days with anti-CD3/CD28 in the
absence or presence of IL-2, Tregs from NOD mice showed to be highly dependent
on IL-2 to maintain Foxp3 expression. Moreover, NOD Tregs become producers of IL-
17 and INF-gamma more easily than Tregs from the other strains. In addition, NOD
Tregs showed lower responsiveness to IL-2, with significantly reduced levels of pSTAT5,
even at high IL-2 doses, with respect to B6 and BALB/c Tregs. Interestingly, NOD Tregs
exhibit differences in the expression of SOCS3, GRAIL, and OTUB1 when compared
with Tregs from B6 and BALB/c mice. Both, at steady state conditions and also after
activation, Tregs from NOD mice showed increased levels of OTUB1 and low levels
of GRAIL. In addition, NOD Tregs had differences in the expression of ubiquitin related
molecules that play a role in the maintenance of Foxp3 cellular pools. Indeed, significantly
higher STUB1/USP7 ratios were detected in NOD Tregs, both at basal conditions and
after stimulation, compared to in B6 and BALB/c Tregs. Moreover, the addition of a
proteasome inhibitor to cell cultures, conferred NOD Tregs the ability to retain Foxp3
expression. Herein, we provide evidence indicating a differential expression of SOCS3,
GRAIL, and STUB1/USP7 in Tregs from NODmice, factors known to be involved in IL-2R
signaling and to affect Foxp3 stability. These findings add to the current knowledge of
the immunobiology of Tregs and may be related to the known insufficiency of Tregs from
NOD mice to maintain self-tolerance.
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INTRODUCTION
The autoimmune prone non-obese diabetic (NOD) mouse
spontaneously develops type 1 diabetes and also thyroiditis,
sialadenitis, and prostatitis with age, therefore serving as an
experimental model to study the mechanisms involved in self-
tolerance breakdown (1). It is well-known that regulatory T
cells that express Foxp3 (Tregs) are pivotal to the maintenance
of tolerance and that a failure in its differentiation results
in fatal autoimmune lymphoproliferative disease (2, 3). In
addition, a wide range of genetic manipulations that impair
Treg cell function or end in decreased Tregs numbers also
result in increased autoimmunity (2, 3). These data have led
to the hypothesis of a possible failure in the numbers and/or
functionality of Treg cell populations in NOD mice (4–8).
Although many researchers tried to answer this interrogation,
current evidence remains controversial (4–8). Some authors
studied the generation and function of Tregs showing reduced
numbers in NOD mice, with data not corroborated by others
who demonstrated increased or similar Tregs numbers (4–8).
In addition, several reports show that the suppressor activity
of Tregs declined with age in the NOD strain (7). However,
a comparative analysis between NOD and C57BL/6 (B6) mice
showed that Tregs were equally functional in both strains (8).
It is well-known that Foxp3, together with other transcription
regulators, induces Tregs development in the thymus (9). T
cell receptor and interleukin-2 receptor-derived signals induce
foxp3 gene expression in developing Tregs (10, 11). IL-2 receptor
ligation induces Foxp3 regulation through the binding of STAT5
to the foxp3 promoter and to a specifically demethylated region
known as Conserved Non-coding Sequence-2 (CNS2). The
CNS2 region is required for the maintenance of the Foxp3
protein expression and stability in Tregs, but not for the
initiation of Foxp3 mRNA transcription (12, 13). Recently, it
has been demonstrated that Foxp3 maintenance is also affected
by inflammatory cytokines and other factors, which alter post-
translational modifications such as ubiquitination, acetylation,
and phosphorylation thus regulating the stability of the cellular
pools of Foxp3 (14). Indeed, Foxp3 stability has been linked
to the activities of the deubiquitinase USP7 and ubiquitinase
STUB1, which respectively avoid or promote Foxp3 proteasome
degradation (15, 16). Thus, in addition to the transcriptional
control of foxp3 expression, other mechanisms of regulation
contribute to the overall abundance and activity of Foxp3,
affecting the functions of Tregs and therefore the maintenance
of self-tolerance.
The interleukin-2 (IL-2) receptor signaling pathway has been
strongly implicated in type 1 diabetes (T1D) susceptibility and
also in other autoimmune diseases (1, 17). Polymorphisms in
IL-2, IL-2Rα, and IL-2Rβ are genetic risk factors for several
autoimmune diseases (1, 17–19). Genomic studies revealed
a significant association between the region encoding IL-2
with T1D, celiac disease, rheumatoid arthritis, autoimmune
thyroid diseases and multiple sclerosis (17–22). Moreover,
NOD mice also showed a strong genetic susceptibility for
autoimmune diabetes mapped to the chromosome 3 region
encompassing the IL-2-IL-21 gene (region Idd3) (1, 23). Mice
possessing susceptibility alleles at Idd3 have reduced IL-2 levels
in comparison to mice with B6-derived alleles. Furthermore,
Idd3 alleles also affect the development of other autoimmune
diseases inNODmice such as Sjogren’s syndromemanifestations,
experimental autoimmune encephalitis and others (1, 23, 24).
It is well-known that IL-2 binding to the IL-2R activates
associated JAK1 and consequently STAT5, and, that activated
STAT5 binds to CNS2 favoring Treg cell stability (25). Once
activated, STAT5 dimerizes and translocates into the nucleus
where it initiates the transcription of different genes, including
negative regulators such as SOCS3. In turn, SOCS3 feeds back
into the signaling cascade desensitizing the IL-2R by inactivating
pJAK1 (26). On the other hand, the ubiquitin- ligase named “gene
related to anergy in lymphocytes” or GRAIL is well-known as an
E3 ubiquitin-protein ligase that participates in anergy signaling
by limiting activation induced by IL-2 (27, 28). Moreover, GRAIL
is regulated by Otubain-1 (OTUB1), a deubiquitinating enzyme
that acts as a destabilizing GRAIL protein (29). Interestingly,
it has been reported that Tregs express 10 times more GRAIL
mRNA than conventional T cells and that GRAIL deficient
Tregs exhibited reduced suppressive function (30). However, it
has not yet been investigated if Tregs from mice with different
susceptibility to autoimmunity have differential expression of
these molecules.
In the present report, by comparing Tregs from the
autoimmune prone NOD mice with B6 and BALB/c mice, we
provide evidence showing that NOD mice exhibit differences in
Treg cell counts and of their ability to be stimulated via TCR
plus IL-2. Our results also demonstrate that Tregs from NOD
mice express reduced and higher levels of GRAIL and SOCS3,
respectively, as well as increased expression of ubiquitinases
known to favor Foxp3 proteasome degradation. Altogether, that




Female, non-diabetic, 4 to 6-week old mice were used in all
the experiments. NOD, B6, and BALB/c mice were purchased
from Jackson Laboratory and then bred and maintained under
specific pathogen-free conditions in the animal facility of the
Centro de Investigaciones en Bioquímica Clínica e Inmunología,
Universidad Nacional de Cordoba, Argentina. Animals were
maintained in a 16 h light−8 h dark cycle, at 20 ± 2◦C, with
food and water ad libitum. All experiments were approved by and
conducted in accordance with the guidelines of the Committee
for Animal Care and Use of the Facultad de Ciencias Químicas,
Universidad Nacional de Córdoba (Res. HCD 240/216), in strict
accordance with the recommendation of the Guide for the Care
and Use of Laboratory Animals of the NIH (NIH publication 86-
23). Animals were not subjected to any treatment. All efforts were
made to minimize suffering and discomfort.
Flow Cytometry
Single cell suspensions were prepared from spleen and lymph
nodes (LN) of individual mice and stained for surface markers.
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Dead cells were excluded using Live-dead fixable (Invitrogen).
The following antibodies were used: CD4, CD25 (PC61), GITR,
CD73, CD39, CD3, CD8, LAG-3, LAP-1, PD-1, PD-L1, pSTAT5,
GRAIL (Abcam, Cambridge, UK), OTUB-1 (Abcam), Ki67, Bcl-
2, STUB-1 (Abcam), and USP7 (Abcam). For intracellular Foxp3,
CTLA-4, and Ki67 staining a Foxp3 Staining Kit (eBioscience)
was used. For the assessment of intracellular GRAIL, OTUB-
1, STUB-1, and USP7 expression, cells were first stained with
surface antibodies and then fixed and permeabilized with the
Foxp3 Staining Kit (eBioscience, San Diego, California, USA)
for 30min followed by reacting with rabbit anti-GRAIL, anti-
OTUB-1, anti-STUB-1, and anti-USP7 primary Ab (Abcam)
for 45min. After washing, cells were stained for 20min
with FITC or Alexa Fluor 647-anti-rabbit IgG (Biolegend,
San Diego, California, USA). Finally, cells were washed twice
with a saline solution of 2% FBS and stored at 4◦C in the
dark until analysis. To measure cytokine production, cells
were activated for 4 h with PMA (50 ng/ml; Sigma-Aldrich),
ionomycin (500 ng/ml; Sigma-Aldrich), and brefeldin A (2µM;
eBioscience) in 96-well U-bottom plates. After cell staining
for surface molecules, cells were fixed and permeabilized with
Staining Set (eBioscience) and stained with anti-mouse IFN-γ
and IL-17 mAb (BD Biosciences) according to the manufacturer’s
instructions. For phospho-STAT5 detection, cells were fixed with
(2% wt/vol) paraformaldehyde for 20min at room temperature,
permeabilized with 100% (vol/vol) methanol for 10min on ice.
After extensive washing, cells were stained with anti-pStat5 (Tyr-
694) (eBiosciences). Data were collected on FACS-CANTO II
or LSRFortessa flow cytometers (BD Biosciences, San Jose, CA,
USA) and analyzed using FlowJo software (version 7.6.2). Proper
compensation using Fluorescence Minus One (FMO) controls
were used.
Cell Purification and Sorting
Cells were obtained from pooled spleens freshly collected by
mechanical disruption. Mononuclear cell suspensions (MNCs)
were prepared under sterile conditions in HBSS (Sigma-
Aldrich, St. Louis, MO, USA) and separated on Ficoll-
Hypaque PREMIUM 1.084 (GE Healthcare Bio-Sciences AB,
Uppsala, Sweden) centrifugation gradients. CD4+ cells were
enriched from MNCs using EasySepTM Mouse CD4+ T Cell
Isolation Kit (StemCel Technologies, Vancouver, Canada).
Finally, CD4+CD25hi cells (Treg) were sorted from CD4+ cells
enriched with a FACSAria (BD Biosciences, San Diego, CA,
USA) on the basis of CD4 and CD25 expression, ensuring
purity greater than 97%. FoxP3 expression was evaluated by
intracellular staining with the FJK-16s mAb (eBioscience).
In vitro Treg Cell Activation
In most experiments, CD4+CD25+ purified T cells were
cultured at a concentration of 0.5 × 106 cells/ml per well in
triplicate for each condition and resuspended in RPMI 1640
(Life Technologies, Carlsbad, CA, USA) supplemented with
10% FBS (Gibco, Waltham, MA, USA), 2mM L-glutamine,
0.1% gentamicin, and 50mM β-Mercaptoethanol. Plates were
incubated with plate-bound anti-CD3/CD28 (1 and 0.25µg/ml,
respectively) (BD Biosciences) and different amounts of rIL-2
(Peprotech, Rocky Hill, NJ, USA) as indicated for 72 h at 37◦C,
5%CO2 incubator. In some experiments the proteasome inhibitor
MG-132 (Sigma-Aldrich) was added at a concentration of 5µM
during the last 12 h of the culture.
RT-PCR Assay
Total RNA was isolated from 3.106 sorted CD4+CD25hi
splenic Treg cells (12 mice per mouse strain) using TRizol
reagent (Invitrogen, Carlsbad, CA, USA) and reverse-transcribed
into cDNA by using Reverse Transcription System (Promega,
Madison. WI, USA). cDNA was amplified by real time PCR with
the predesigned TaqMan gene expression assays and reagents
(Applied Biosystems, Foster City, CA, USA), according to the
manufacturer’s instructions. Probes with the following Applied
Biosystems assay identification numbers were used: Rnf128,
Mn00480990.m1 and Rn18s, Mn03928990.g1 (31). For each
sample, mRNA abundance was normalized to the amount
of 18S RNA and expressed as arbitrary units. The primers
used for amplification of OTUB1, SOCS3, STUB1, and USP7
genes were: OTUB1_F: 5′-CGACTCCGAAGGTGTTAACTG T-
3′, and OTUB1_R: 5′-GAG GTCCTT GAT CTT CTG TTG G-3′
(Macrogen, Seoul, Korea), SOCS3_F: 5′-TGC GCC TCA AGA
CCT TCA G-3′, and SOCS3_R: 5′-GCT CCA GTA GAA TCC
GCT CTC-3′ (Macrogen); STUB1_F: 5′-CCC CCG CCC CTC
CCG CAC TC-3′, and STUB1_R: 5′-CAT GCC AGC TCC GCC
CCA CA-3′ (Macrogen); USP7_F: 5′-CCC TCC GTG TTT TGT
GCG A-3′, and USP7_R: 5′-GAC CAT GAC GTG GSS TCA GA-
3′ (Macrogen). The primers used for normalization were eef2
housekeeping gene as follows: F: 5′-AAG CTG ATC GAG AAG
CTG GA-3′, and R: 5′-CCC CTC GTA TAG CAG CTC AC-
3′ (Sigma-Aldrich). Quantitative real time PCR was performed
on a StepOneTM instrument (Life Technologies) using SYBR R©
Select Master Mix (Life Technologies). Each qPCR experiment
was performed at least in triplicates, in a final volume of 20 µl.
After performing thermal cycling, qPCR amplification data were
analyzed using StepOne software (Applied Biosystems).
Statistical Analysis
Statistical analysis was performed using one or two-way ANOVA
with Bonferroni post-hoc test analysis. Data are shown as mean
± SEM in the graphs. Statistical tests were performed using the
GraphPad Prism 7.0 software (GraphPad Software Inc., La Jolla,
CA, USA). P-values ∗ < 0.05, ∗∗ < 0.01, ∗∗∗ < 0.001, and ∗∗∗∗ <
0.0001 were considered significant in all analyses.
RESULTS
Reduced Treg Cell Counts and Tregs
Foxp3/CD25 Expression in NOD Mice
Variable data have been reported on the proportion of Tregs in
the autoimmune prone NOD mice with respect to B6 mice and
other mouse strains (4, 6). We first analyzed the frequencies of
CD4+Foxp3+CD25+Tregs among NOD, B6, and BALB/c mice
from our animal facility colony. All mice analyzed were young
(4 to 6-week old) to ensure they were neither pre diabetic nor
have T-cell infiltration in pancreas or other tissues. Foxp3+
cell frequencies and absolute numbers were analyzed within
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single positive (CD4+CD8−) thymic cells and CD4+ cells from
spleen and lymph nodes following gating strategies represented
in Supplementary Figure 1. Significantly reduced frequencies of
CD4+Foxp3+ Tregs were observed in thymus and spleen from
NOD and B6 mice with respect to BALB/c mice (Figure 1A).
In addition, NODmice showed significantly reduced frequencies
of Foxp3+ Tregs in pooled inguinal and popliteal lymph nodes
(pLN) than B6 and BALB/c mice (Figure 1A). When analyzing
absolute counts of CD4+Foxp3+ Treg cells, decreased numbers
were observed in the spleen and pLN (but not in the thymus)
from NOD mice with respect to the other mouse strains
(Figure 1B). Analyses of the relative expression of Foxp3 on
Tregs from different tissues revealed that spleen Tregs fromNOD
mice expressed significantly lower protein levels when compared
with those from BALB/c mice, whereas no differences were
observed between Tregs fromNOD and B6mice (Figures 1C,D).
Similar results were observed when analyzing Foxp3 expression
in pLN Tregs, where more elevated Foxp3 levels were detected
in BALB/c Tregs than B6 Tregs, whereas NOD Tregs presented
the lowest values. Interestingly, Foxp3 expression did not
significantly differ among thymus Tregs from the mouse strains
under study, indicating that Tregs egress from the thymus
expressing comparable amounts of Foxp3. In accordance, similar
levels of CD25 expression were detected in thymus Tregs from
the different mouse strains under study, although lower levels
were observed in spleen and pLN Tregs from NOD mice with
respect to B6 and BALB/c mice (Figures 1E,F). Altogether, these
results indicate that NOD mice have a generalized defect in
maintaining Treg cell numbers and Foxp3 Treg cell levels in
secondary lymphoid organs.
Tregs From NOD Mice Show a Decreased
Response to TCR Plus IL-2 Stimulation
In classical in vitro Tregs function assays, Tregs and T effector
cells are placed together so interpretation of results is sometimes
difficult (3, 32). Available reported evidence indicates both,
greater resistance to suppression of T effector cells and lower
suppressor capacity of Tregs fromNODmice (8, 33–35). For that
reason, sorted CD4+CD25hi T cells (purity > 97%) were in vitro
stimulated for 3 days to assay functional response of Tregs from
the different mouse strains after TCR ligation in the presence
of IL-2. Gated CD4+Foxp3+ cells (Supplementary Figure 2)
were assayed for the expression of different molecules related
to functional activity. After 3 days of αCD3/CD28 stimulation
in the presence of IL-2, an important up regulation of different
molecules involved in Treg functional activity was observed
in Tregs from all mouse strains under study (Figures 2A,B).
Stimulated Tregs showed enhanced expression of CD25, LAP-1,
CD73, CD39, PD1, PDL1, and LAG-3. Approximately, a 2-fold
increase in the expression of CD25 was detected in stimulated
Tregs from NOD and B6 mice with, which was significantly
lower to that observed in stimulated Tregs from BALB/c mice
(Figures 2A,B). The expression of LAP-1 also showed a 2-fold
increase in stimulated Tregs from NOD and BALB/c mice, while
Tregs from B6 mice showed a 4-fold increment for this cell
marker. CD73 expression showed a similar increment in all
mouse strains under study, while GITR expression did not show
important increments after stimulation (Figures 2A,B). CD39
expression increased six to seven times in stimulated Tregs
cells from NOD and BALB/c mice, while a significantly greater
increase was detected in stimulated Treg cells from B6 mice. In
the case of PD1 and PD-L1, stimulated Treg cells from NOD
mice showed smaller increments when compared with stimulated
Tregs from the other mouse strains. Finally, LAG-3 expression
showed a 4-fold increase in stimulated Tregs from BALB/c mice,
with lower increments in stimulated Tregs from NOD and B6
mice. We also assessed intracellular Ki67 expression as a marker
of in vitro cell proliferation. Significantly reduced expression of
Ki67 was observed in Tregs from NOD mice upon TCR ligation
plus IL-2 stimulation when compared with B6 and BALB/c mice
(Figure 2C). Altogether, these results show that, after TCR plus
IL-2 stimulation, Tregs from NOD mice respond more weakly,
with a lower proliferative capacity and decreased expression of
molecules involved in regulatory functions.
Tregs From NOD Mice Show Less in vitro
Stability in Conditions of Low IL-2
Abundance
We next compared Foxp3 expression in Tregs from the different
mouse strains under limiting trophic cytokine conditions, which
has been shown to lead to a gradual loss of Foxp3 (36,
37). Sorted CD4+CD25hi (>97% CD4+Foxp3+) were in vitro
cultured with αCD3/CD28 plate-bound antibodies in the absence
or presence of increasing doses of IL-2 (Figure 3). After 3
days of culture with αCD3/CD28 stimulation without IL-2
addition, CD4+Foxp3+ cell frequencies decreased significantly
in cultured Tregs from all mouse strains, but to a minor
extent in Tregs from BALB/c mice (Figures 3A,B). In the
absence of IL-2 more than 80% of cultured Treg cells from
BALB/c mice were Bcl-2+ (Figure 3C), and ∼60% were able to
proliferate (Figure 3D). The opposite pattern was observed in
cultured Tregs from NOD mice. The absence of IL-2 caused
an important fall in the frequencies of CD4+Foxp3+ cells
(Figures 3A,B) accompanied with the lowest counts of Bcl-2+
cells (Figure 3C), and ∼5% of proliferating cells (Figure 3D).
An intermediate pattern was observed in sorted Tregs from
B6 mice, in which 70% of cells were Bcl-2+ and a little
more than 5% of were proliferating cells. The presence of IL-
2 during stimulation allowed the maintenance of Foxp3, Bcl-
2, and Ki67 expression in high percentages of cultured Tregs
from B6 and BALB/c mice. However, only high IL-2 doses
allowed the ability to keep Foxp3 expression in about 70%,
and Bcl-2 expression in more than 90% of cultured Tregs
from NOD mice, highlighting the crucial importance of IL-
2 as a survival factor for Tregs, especially for those derived
from NOD mice (Figures 3A–D). When analyzing not only
frequencies of positive cells, but also Foxp3 expression levels
under experimental conditions, we observed that Tregs from
BALB/c mice maintained Foxp3 expression levels under TCR
stimulation without IL-2 and significantly increased them in
a dose dependent manner when cells were stimulated with
the further addition of IL-2 (Figure 3E). Tregs from B6 mice
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FIGURE 1 | Reduced Treg cell counts and Tregs Foxp3/CD25 expression in NOD mice. (A) Scatter plots show the frequency of Foxp3+CD4+CD25+ (Treg) cells in
the CD4+ live cell population of the thymus, spleen, and a pool of inguinal and popliteal lymph nodes (pLN) from 4 to 6-week old NOD, B6, and BALB/c mice. (B)
Absolute numbers of Treg cells in the thymus, spleen, and pLN from NOD, B6, and BALB/c mice. (C) Bar graph showing Mean Fluorescence Intensity (MFI) values for
Foxp3 in Tregs from the thymus, spleen, and pLN from NOD, B6, and BALB/c mice. (D) Representative histograms of Foxp3 expression in Tregs from the thymus,
spleen, and pLN in all strains under study. (E) Bar graph showing MFI values for CD25 in Tregs from the thymus, spleen, and pLN from NOD, B6, and BALB/c mice.
(F) Representative histograms of CD25 expression on CD4+ cells from the thymus, spleen, and pLN in all the mouse strains under study. Gates were performed on
viable cells using Live-dead fixable (Invitrogen) dye and Fluorescence Minus One (FMO) controls. Data are shown as mean ± SEM, n = 4–8 mice per group, and are
representative of three independent experiments with essentially the same results. The p-values were obtained using one-way ANOVA followed by Bonferroni
post-hoc analysis as appropriate. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
also maintained Foxp3 expression levels under TCR stimulation
without IL-2 and after stimulation with increasing IL-2 doses
enhanced Foxp3 levels but reaching values lower than those
of Tregs from BALB/c mice. Remarkably, NOD Tregs showed
a significant loss of Foxp3 expression after stimulation for 3
days with αCD3/CD28 without IL-2. However, enhanced Foxp3
expression was observed when NOD Tregs were stimulated
with αCD3/CD28 plus high IL-2 doses, although never reaching
the values observed in Tregs from the other mouse strains
(Figure 3E). These results indicate that Tregs from NOD mice
are strongly dependent of IL-2 to survive and retain Foxp3
expression levels. On the contrary, Tregs from BALB/c mice were
the most stable ones under the experimental conditions assayed.
Besides being able to maintain Foxp3 expression, Tregs from
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FIGURE 2 | Tregs from NOD mice show low responsiveness to TCR plus IL-2 stimulation. (A) Representative histograms of CD25, GIRT, CD73, CD39, LAP-1, PD-1,
PD-L1, and LAG-3 expression in purified splenic Treg (CD4+CD25hi) cells from NOD, B6, and BALB/c mice without stimulation and after αCD3/CD28 plus rIL-2
stimulation (100 UI/ml). (B) Bar graph showing values of MFI fold change relative to values found in purified unstimulated Tregs from the mouse strains under study.
(C) Bar graph showing values of Ki67+ Tregs percentage fold change relative to values found in unstimulated Tregs from the mouse strains under study. Gates were
performed on viable cells using Live-dead fixable (Invitrogen) dye and Fluorescence Minus One (FMO) controls. To purify Tregs, 12 mice per mouse strain were used.
Data correspond to at least four replicates (mean ± SEM) of a single sample for each condition and mouse strain analyzed. The analysis is representative of at least
three independent experiments with essentially the same results. The p-values were obtained using one-way ANOVA followed by Bonferroni post-hoc analysis as
appropriate. *p < 0.05 and **p < 0.01.
BALB/c mice also increased more than three times its expression
levels after stimulation with IL-2 (Figure 3E).
Using standard expansion protocols (αCD3/CD28 plus IL-
2), it has been shown that an important Treg cell expansion
can be achieved in vitro, but also that a fraction of cells
loose Foxp3 expression and start producing IL-17 and IFN-γ
(14, 38). Although at day zero IL-17+ or INF-γ+ cells were
no detected (<0.1% for all strains, data not shown) in our
setting, after 3 days of culture with αCD3/CD28 plus IL-2
stimulation higher percentages of Foxp3− (ex-Treg) and Foxp3+
cells also expressing IL-17 or INF-γ were detected in cultured
Tregs from NOD mice with respect to the other mouse strains
(Figures 3F,G). These data suggest that Tregs from NOD mice
have a higher dependence on IL-2 to maintain Foxp3 expression
and they lose its expression and become producers of IL-17 and
INF-γ more easily than Treg cells from the other mouse strains.
Tregs From NOD Mice Show Lower
Responsiveness to IL-2 Stimulation and
Exhibit Differences in the Expression of
SOCS3, GRAIL, and OTUB1
Since the decreased responsiveness to IL-2 could be due to altered
IL-2 receptor signaling, we assayed the phosphorylation status
of STAT5 (pSTAT5) in Tregs from the mouse strains under
study at different time-points after in vitro stimulation with
high doses of IL-2 (Figures 4A,B). As shown in Figure 4A, no
changes in pSTAT5 levels were observed in the absence of IL-
2 for all time-points and samples analyzed (dotted lines). After
IL-2 stimulation, increased levels of pSTAT5 were detected in
Tregs from all mouse strains reaching peak values at 30min post
stimulus, with the highest and lowest levels observed in Tregs
from BALB/c and NOD mice, respectively (Figure 4A). Analysis
performed after 60min of IL-2 stimulation revealed a decline in
pSTAT5 levels in Tregs from all the mouse strains under analysis,
althoughmaintaining the differences of expression amongmouse
strains (Figures 4A,B). It is interesting to highlight that even
at high doses of IL-2, STAT5 activation in NOD Tregs did
not reach the values observed in Tregs from the other mouse
strains (Figures 4A,B).
Next, we performed experiments to investigate whether Tregs
from NOD mice had differences in the expression of the
IL-2 signaling cascade regulators such as SOCS3, a negative
regulator of pJAK1 (25). In addition, we analyzed if Tregs from
NOD mice had differences in the E3 ubiquitin ligase GRAIL
and its regulator OTUB1 (27–29). As shown in Figure 4C,
higher levels of SOCS3 and OTUB1 mRNA were detected in
purified Tregs from NOD mice with respect to B6 and BALB/c
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FIGURE 3 | Tregs from NOD mice show less in vitro stability in conditions of low IL-2 abundance. (A) Bar graph showing the frequencies of Foxp3+CD4+ cells at days
0 and 3 after stimulation with αCD3/CD28 in the absence or presence of rIL-2 (50–200 UI/ml). (B) Representative contour plots and histograms of Foxp3 expression
in sorted splenic Treg (CD4+CD25hi) cells from NOD, B6, and BALB/c mice at day 0 and after 3 days of stimulation with αCD3/CD28 in the absence or presence of
rIL-2. (C) Bar graph showing the frequency values of CD4+Foxp3+Bcl-2+ cells at days 0 and 3 after stimulation with αCD3/CD28 in the absence or presence of rIL-2
(200 UI/ml). (D) Bar graphs showing the frequencies of CD4+Foxp3+Ki67+ cells at days 0 and 3 after stimulation with αCD3/CD28 in the absence or presence of rIL-2
(50–200 UI/ml). (E) Bar graph showing MFI values for Foxp3 in CD4+Foxp3+ cells at days 0 and 3 after stimulation with αCD3/CD28 in the absence or presence of
rIL-2 (50–200 UI/ml). (F) Bar graphs showing the frequencies values of CD4+Foxp3− (non-Tregs) and CD4+Foxp3+ (Tregs) expressing IL-17+ and INF-γ+ cells after 3
days of culture with αCD3/CD28 plus rIL-2 (200 UI/ml). (G) Representative contour plots showing the frequencies of CD4+Foxp3+ and CD4+Foxp3− cells producing
IFN-γ and IL-17 after 3 days of culture with αCD3/CD28 plus rIL-2 (200 UI/ml). Gates were performed on viable CD4+ cells using Live-dead fixable (Invitrogen) dye
and Fluorescence Minus One (FMO) controls. To purify Tregs, 12 mice per strain were used. Data correspond to at least four replicates (mean ± SEM) of a single
sample for each condition and mouse strain analyzed. The analysis is representative of at least three independent experiments with essentially the same results. The
p-values were obtained using one-way ANOVA followed by Bonferroni post-hoc analysis as appropriate. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
mice. On the contrary, lower levels of GRAIL mRNA were
detected in Tregs from NOD and B6 mice (Figure 4C). The
analysis of protein expression was performed in unstimulated
and stimulated Tregs from all mouse strains (Figure 4D). Lower
levels of GRAIL were observed in unstimulated Tregs from NOD
mice when compared with B6 and BALB/c mice, whereas the
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FIGURE 4 | Tregs from NOD mice show low responsiveness to IL-2 stimulation and exhibit differences in the expression of SOCS3, GRAIL, and OTUB1. (A) Mean
Fluorescence Intensity for pSTAT5 after 0, 30, and 60min of stimulation with or without rIL-2 (200 UI/ml). Values in the absence of IL-2 for all time-points are
represented by dotted lines. (B) Representative histograms of pSTAT5 expression in sorted splenic Treg (CD4+CD25hi) cells from NOD, B6, and BALB/c mice after 0,
30, and 60min of stimulation with rIL-2 (200 UI/ml). (C) Bar graphs of mRNA for SOCS3, GRAIL, and OTUB1 from sorted splenic Tregs from NOD, B6, and BALB/c
mice. (D) Bar graphs (left) and representative histograms (right) showing MFI for GRAIL and OTUB1 in purified splenic Tregs from NOD, B6, and BALB/c mice,
unstimulated or stimulated with rIL-2 during 30min. (E) Bar graphs showing frequencies of GRAIL+ and OTUB1+ cells in unstimulated and rIL-2 stimulated Tregs from
NOD, B6, and BALB/c mice (30min). (F) GRAIL/OTUB1 MIF ratios in unstimulated and stimulated Tregs from NOD, B6, and BALB/c mice. To purify Tregs, 12 mice
per strain were used. Data correspond to at least four replicates (mean ± SEM) of a single sample for each condition and mouse strain analyzed. The analysis is
representative of at least three independent experiments with essentially the same results. The p-values were obtained using one- and two-way ANOVA followed by
Bonferroni post-hoc analysis as appropriate. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
expression of the OTUB1 protein showed the opposite pattern
(Figure 4D). After IL-2 stimulation, an important up regulation
of GRAIL and OTUB1 was observed in Tregs from all mouse
strains under study (Figure 4D). However, NOD and B6 Tregs
expressed significantly lower levels of GRAIL and enhanced
levels of OTUB1 with respect to BALB/c mice (Figure 4D).
The frequencies of GRAIL+ or OTUB1+ were not different
among unstimulated Tregs from mouse strains under study
(Figure 4E). However, after stimulation the highest proportion
of GRAIL+ cells were detected in stimulated Tregs from BALB/c
mice, with intermediate values in Tregs from B6 mice and the
lowest percentages in Tregs from NOD mice (Figure 4E). On
the contrary, higher frequencies of OTUB1+ cells were detected
in stimulated Tregs from NOD and B6 mice (Figure 4E). When
the GRAIL/OTUB1 ratio was analyzed, significantly lower values
were observed in NOD Tregs at basal conditions (unstimulated
cells, Figure 4F). In addition, GRAIL/OTUB1 ratios after IL-
2 stimulation, showed significantly lower values in the NOD
and B6 Tregs than in Tregs from BALB/c mice (Figure 4F).
Interestingly, GRAIL and OTUB1 expression levels showed no
differences between NOD and B6 Tregs (Figure 4D). However,
the GRAIL/OTUB1 ratio was higher in unstimulated Tregs
from B6 mice with respect to NOD mice, showing again that
highly and mildly susceptible mice to develop autoimmunity
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may share some Tregs features. These data indicate that Tregs
from NOD mice show decreased STAT5 activation accompanied
with the highest SOCS3 expression and lowest GRAIL/OTUB1
expression ratio.
Treg From NOD Mice Show Higher
Expression of Ubiquitination Related
Molecules
Foxp3 post-translational modifications such as ubiquitination
by STUB-1 or deubiquitination by USP7 are known to either
deplete or stabilize the cellular pools of Foxp3, respectively
(39, 40). Taking that into account, we performed experiments
to investigate whether Tregs from NOD mice had differences in
the expression of molecules involved in ubiquitination processes
in steady state conditions. As can be seen in Figure 5A, higher
levels of STUB1 mRNA were detected in purified Tregs from
NOD mice with respect to B6 and BALB/c mice. On the
contrary, lower levels of USP7 mRNA were detected in Tregs
from NOD and B6 mice (Figure 5A). The analysis of protein
expression revealed lower levels of USP7 in unstimulated Tregs
fromNODmice when compared with Tregs fromB6 and BALB/c
FIGURE 5 | Tregs from NOD mice show high expression of ubiquitination related molecules. (A) Bar graphs of mRNA for STUB-1 and USP7 from sorted splenic Treg
cells of NOD, B6, and BALB/c mice. (B) Bar graphs showing MFI for STUB-1 and USP7 in unstimulated and stimulated purified splenic Treg cells from NOD, B6 and
BALB/c mice. (C) Representative histograms of STUB-1 and USP7 expression in unstimulated and αCD3/CD28 plus rIL-2 stimulated Treg cells from NOD, B6, and
BALB/c mice (D) STUB-1/USP7 MFI ratio in unstimulated and stimulated Treg cells from NOD, B6 and BALB/c mice. (E) Frequencies (left) and representative contour
plots (right) of purified Treg cells in vitro stimulated with αCD3/CD28 plus or without rIL-2 for 3 days, and in the absence or presence of the proteasome inhibitor
MG-132. The proteasome inhibitor MG-132 was added at a concentration of 5µM during the last 12 h of the culture. (F) STUB-1/USP7 MFI ratios of CD4+Foxp3+
Treg cells from NOD, B6, and BALB/c mice after 3 days of stimulation with rIL-2 plus rIL-6 or rIFN-γ. To purify Tregs, 12 mice per strain were used. Data correspond to
at least four replicates (mean ± SEM) of a single sample for each condition and mouse strain analyzed. The analysis is representative of at least three independent
experiments with essentially the same results. The p-values were obtained using one-way ANOVA followed by Bonferroni post-hoc analysis as appropriate. *p < 0.05,
**p < 0.01, ***p < 0.001, and ****p < 0.0001.
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mice (Figures 5B,C). The opposite pattern was observed for
STUB1, which expression was higher in unstimulated Tregs from
NOD mice when compared with Tregs from B6 and BALB/c
mice (Figures 5B,C). The expression of STUB1 and USP7 was
also analyzed after 3 days of culture with αCD3/CD28 plus
or without IL-2 stimulation. On the one hand, the highest
levels of STUB1 expression were consistently detected in Tregs
from NOD and B6 mice cultured with αCD3/CD28 with or
without the addition of IL-2 (Figures 5B,C). On the contrary,
Tregs from BALB/c mice showed significantly lower levels of
STUB1 expression with respect to Tregs from B6 and NOD
mice (Figures 5B,C). On the other hand, USP7 expression was
lower in stimulated Treg cells from BALB/c mice than in
stimulated Tregs from NOD and B6 mice (Figure 5D). When
STUB1/USP7 expression ratios were analyzed, significantly
higher values were detected in Tregs from NOD mice at basal
conditions with respect to Tregs from the other mouse strains
analyzed (unstimulated, Figure 5D). Moreover, STUB1/USP7
expression ratio analyzed in Tregs stimulated with αCD3/CD28
plus IL-2, showed significantly higher values in Tregs from
NOD mice with respect to Tregs from B6 and BALB/c mice
(Figure 5D). In addition, NOD Tregs were stimulated with
αCD3/CD28 with or without IL-2 in the absence or presence
of the proteasome inhibitor MG132 (Figure 5E). Interestingly,
NOD Tregs stimulated with only αCD3/CD28 in the presence
of MG132 retained Foxp3 expression levels comparable to
those observed in Tregs stimulated with αCD3/CD28 plus IL-
2, suggesting that Foxp3 instability was related to proteasome
activity (Figure 5E). Since the ubiquitin-dependent degradation
of Foxp3 in Tregs can be triggered by exposure to inflammatory
stress in vitro, we also analyzed STUB1/USP7 expression after
stimulation with αCD3/CD28 and IL-2 plus IL-6 or INF-γ. As
shown in Figure 5F, under stress signals, Tregs from NOD mice
show higher STUB1/USP7 ratios. Indeed, in the presence of
IL-6, both B6 and NOD Tregs showed higher STUB1/USP7
ratios with respect to Tregs from BALB/c mice. With the
addition of INF-γ, NOD Tregs showed a significantly increased
STUB1/USP7 expression ratio than Tregs from the other two
mouse strains (Figure 5F). Interestingly, under some stressful
conditions (abundance of IL-6), the STUB1/USP7 ratio showed
no differences between Tregs fromNOD and B6, suggesting once
again that highly and mildly autoimmune-prone mouse strains
may share some Tregs features. Altogether, these results suggest
that the high expression levels of STUB1 observed in NOD Tregs
could be favoring the loss of Foxp3 because of the induction of its
proteasome degradation.
DISCUSSION
Although the IL-2/IL-2R signaling pathway has been the focus
of several studies, certain aspects of its molecular regulation are
still not well-characterized, and a more complete understanding
of the pathway is necessary. IL-2 is essential for the maintenance
of Tregs since, in its absence, a profound deficiency of Tregs
occurs leading to autoimmunity (41). Studies of IL-2 and CD25
deficiency have shown that thymus generation of Foxp3+ Tregs
may be only partially dependent on IL-2 (41–43). However, as
shown by several experimental approaches, IL-2 is critical for the
maintenance of functional Tregs in periphery (41–43). Certainly,
it has been demonstrated that IL-2 is required for the stable
expression of Foxp3 and other mediators of suppressor activity
in Tregs (44).
Within 20 insulin-dependent diabetes (Idd) genetic regions
associated with TID susceptibility and resistance, the Idd3 region
includes genes encoding IL-2 and IL-21 (45). Indeed, the NOD
Idd3 locus has been associated with reduced IL-2 expression,
alterations in Treg cell pools and development of autoimmune
diseases such as autoimmune diabetes, autoimmune ovarian
dysgenesis, and autoimmune sialadenitis (1, 22, 24, 45–47).
However, low IL-2 levels seem not to be only responsible for
Tregs alterations since NOD mice containing B6-derived Idd3
locus produce twice more IL-2 than wild type NOD but show
a modest increase in the frequency of Tregs (22). In addition,
when IL-2/anti-IL-2 complex therapy was used to treat NOD
mice, Tregs responded poorly suggesting that both, limited
IL-2 availability and defects in the IL-2R signaling, could be
underlying factors involved in NOD Tregs alterations (48).
In the present work, conducting a comparative study between
young NOD, B6, and BALB/c mice, we found that NOD
mice showed reduced Treg cell numbers and reduced Foxp3
expression in Tregs in secondary lymphoid organs, but not in the
thymus, suggesting that reduced pools of Tregs in NOD mice do
not result from biased thymic differentiation. Moreover, our data
demonstrated no differences between strains in Foxp3 expression
in thymic Tregs, indicating that when Tregs leave the thymus
they express comparable amounts of Foxp3 and that defects in
maintaining Tregs numbers and Foxp3 expression levels may
occur later in periphery.
It is known that when IL-2 is added to in vitro cultures,
it reverses the anergic, non-proliferative phenotype of Tregs
and promote their capacity to suppress immune responses.
Results from classic Tregs functional assays performed with
NOD cells reported both, Treg cell dysfunction and also T
effector cell resistance to suppression, running in parallel (8, 33–
35). In the present work, we evaluated Treg cell functional
activation by analyzing the response of sorted Tregs after TCR
ligation plus IL-2 stimulation. Even in the presence of high
levels of IL-2, Tregs from NOD mice showed a lower degree
of activation when compared with Tregs from the other mouse
strains (B6 and BALB/c). Upon activation, Tregs from NOD
mice exhibited lower upregulation of molecules associated to
Treg cell function such as LAP-1, LAG-3, PD-1, PD-L1, and
CD39, suggesting reduced suppressor capacity in agreement with
previously reported data (6, 8, 49). Moreover, lower proliferation
ability was observed in stimulated Tregs from NOD mice
indicating that NOD Tregs are less able to become activated and
proliferate upon stimulation with αCD3/CD28 plus IL-2, even if
abundant amounts of IL-2 are available. In a similar way to that
reported in in vitro experiments, after in vivo administration of
IL-2/anti-IL-2 complex therapy a weak expansion of Tregs and
suboptimal protection against diabetes was observed in NOD
mice (48), indicating that the sole administration of IL-2 fails
to completely raise Treg cell numbers in NOD mice. For most
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of the parameters analyzed we found major differences between
NOD and BALB/c mice Tregs, while to a lesser extent between
NOD and B6 Tregs. The latter may explain the controversial
evidence currently reported about NOD Tregs and reinforces
the fact that B6 mice are a mildly autoimmune-prone (50, 51).
Interestingly, our data show that BALB/c mice have elevated
counts of Tregs, which are able to be strongly activated and not
so dependent on IL-2, data that could be related, at least in part,
to the greater susceptibility to tumor development reported in
this strain (52). In the same way, for many of the parameters
analyzed, no differences were observed between Tregs from
NOD and B6 mice (i.e., similar quantities, similar levels of
Foxp3, CD25, PD-L1, and LAG-3 expression after stimulation),
suggesting that some Tregs features are shared by highly and
mildly autoimmune-prone mouse strains. These similarities in
some Tregs characteristics could explain the susceptibility to
the induction of several autoimmune diseases (autoimmune
encephalitis, myasthenia gravis, uveitis, etc.) upon immunization
with autoantigens plus adjuvants shown by B6 mice (53, 54).
Reported in vitro assays have shown that, in the absence
of IL-2, actively proliferating Tregs loose Foxp3 expression at
an accelerated rate (37, 38). Diminished maintenance of Foxp3
expression in Tregs from T1D patients have also been reported
(55). Indeed, Tregs from T1D patients showed decreased pSTAT5
in response to both, high and low doses of IL-2 stimulation.
Authors proposed that decreased pSTAT5 could be due to
alterations in the level of expression of molecules involved in
IL-2R signaling and demonstrated increased expression of the
negative regulator PTNP2 in T1D patients (55). IL-2 dependent
STAT5 signaling in Tregs from NOD and B6 mice was also
analyzed by James et al. showing that IL-2 signaling mechanisms
are functional in NOD Tregs but requires a prolonged stimulus
and high IL-2 concentrations (49). In full agreement, our results
indicate that, in the absence or presence of low levels of IL-2,
NOD Tregs fail to maintain Foxp3 expression in vitro. On the
contrary, most BALB/c Tregs maintained Foxp3 expression, anti-
apoptotic and proliferation markers even in the absence of IL-2.
The stability of Foxp3 expression has been shown to be associated
with DNA hypomethylation at specific CpG-containing regions
of the foxp3 locus, in particular the CNS2 region (56), which
is crucial to stabilize Foxp3 expression (57). Although in the
present work we did not analyze this aspect, studies comparing
the proportion of methylated CpG at the Foxp3 locus in Tregs
fromNOD, B6, and BALB/cmice have shown essentially identical
patterns for all the mouse strains (50). That suggests that Foxp3
instability would not be consequence of epigenetic changes but
rather to a lower sensibility to limited supplies of IL-2 and/or
lower IL-2R signaling response.
SOCS3 is a negative feedback inhibitor that reduces signaling
by IL-2R, being scarcely expressed by Tregs in contrast to
the abundant expression reported in conventional T cells (58).
Tregs express little or no SOCS3 protein either when freshly
isolated or in response to in vitro stimulation (26). It has been
proposed that Tregs maintain low levels of SOCS3 in situations
when responsiveness to IL-2 is required, allowing a prompt
response to IL-2 (26). Interestingly, SOCS3 overexpression
affects the phenotype and function of Tregs (58). By using a
recombinant retrovirus that allow SOCS3 protein expression,
it has been shown that SOCS3-overexpressing Tregs exhibited
reduced proliferation in response to TCR stimulation, being this
effect even more pronounced in the presence of IL-2. In addition,
SOCS3 overexpression in Tregs impaired the ability to maintain
Foxp3 expression and reduced suppressive activity (58). In the
present report, we showed that, upon stimulation, Tregs from
NOD mice exhibited low STAT5 responses, low upregulation of
functional molecules, low proliferation rates and also high levels
of expression of SOCS3 mRNA suggesting that this negative
feedback inhibitor could be involved in the abnormal functions
reported for NOD Tregs.
It has been reported that GRAIL is highly expressed in
Tregs. Moreover, its forced expression by conventional T cells
favors their conversion to iTregs (28, 59). Furthermore, GRAIL-
deficient mice are resistant to immune tolerance induction
and exhibit greater susceptibility to autoimmune diseases than
wild-type mice. Analysis of Treg cell populations in GRAIL-
deficient mice showed that GRAIL-deficient Tregs displayed
reduced suppressive function and increased Th17 cell-related
gene expression (59). Due to its known ubiquitin ligase activity,
it would be interesting to know all the putative protein substrates
of GRAIL. It has been demonstrated that GRAIL is involved
in the degradation of the TCR-CD3 complex through the
ubiquitin-dependent proteasome degradation pathway. Indeed,
by targeting TCR-CD3 for degradation, GRAIL restricts NFATc1
expression in Tregs and naïve T cells (59). Additionally,
it has been shown that GRAIL regulates the expression
of the costimulatory molecule CD40L on CD4T cells by
ubiquitination (60). Interestingly, CD40/CD40L interaction
it has been reported that regulates CD4+CD25+ Treg cell
homeostasis (61). Furthermore, it has been reported that GRAIL
ubiquitinates and degrades CD83 on CD4T cells, a molecule
which expression on Tregs is essential for their differentiation
upon activation (62, 63). Curiously, it has been suggested
that GRAIL could affect SOCS3 E3 ligase activity, thereby
obstructing pJAK1 degradation. pJAK1 degradation is normally
accomplished by the formation of SOCS3 multiunit ubiquitin
“cullin ring ligase” complexes, thus stopping pSTAT5 mediated
transcription and allowing prolonged transcription of Tregs
centric genes under the control of STAT5b (64, 65). In Tregs,
the signaling cascade downstream IL-2R permitted markedly
prolonged activity of pSTAT5. It is possible that GRAIL’s
presence in Tregs would allow prolonged activation of pJAK1
by preventing SOCS3 E3 ligase activity that normally degrades
pJAK1 (66). In the present work, we report lower mRNA and
protein levels of GRAIL in Tregs from NOD mice with respect
to B6 and BALB/c mice. In addition, we report enhanced levels of
the GRAIL’s regulator OTUB1, suggesting that a reduced GRAIL
activity could be impairing IL-2R signaling. To our knowledge,
this is the first report not only describing the expression levels
of GRAIL and OTUB1 in Tregs from different mouse strains,
but also showing that Tregs from autoimmune-prone mice have
diminished levels of GRAIL. Interestingly, reduced GRAIL and
Cbl-b levels have been reported in CD4+ T cells from lupus
patients, a defect that correlated with reduced numbers of Tregs
in periphery (67).
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Finally, the levels of STUB-1 and USP7, enzymes reported
to affect Foxp3 cellular deposits in Tregs (14, 39, 40, 68),
were also evaluated in the present study. Our results showed
enhanced levels of the ubiquitination enzyme STUB-1 and
diminished levels of the deubiquitinating protease USP7 in
Tregs from NOD mice when compared with B6 and BALB/c
mice. We also observed enhanced STUB1/USP7 ratios in NOD
Tregs both, under TCR plus IL-2 stimulation and also under
inflammatory stress signals. Remarkably, in the presence of a
proteasome inhibitor, Tregs from NOD mice were able to retain
Foxp3 expression to levels comparable to those observed in
conditions of TCR stimulation plus high doses of IL-2, suggesting
the proteasome participation in Foxp3 instability. On the one
hand, it has been described that USP7 in Tregs is capable of
interacting with Foxp3 to catalyze its deubiquitination (40, 69).
Moreover, van Loosdregt et al. have shown that knocking down
USP7 reduces Foxp3 levels in Tregs and inhibits its functions
(40). These authors have also shown that the overexpression of
USP7 in Tregs increases Foxp3 protein levels (40). Besides, the
conditional deletion of USP7 in Tregs leads to a dramatic loss of
immune regulation and to lethal autoimmunity, indicating the
need to counteract the process of Foxp3 ubiquitination in order
to maintain a functional and stable pool of Tregs in periphery
(14). In agreement with all these reported data, our results
suggest that individuals in whom lower Tregs USP7 activity is
observed would be those in which lower quantities of Tregs and
lower Foxp3 expression are found. On the other hand, ectopic
STUB1-mediated Foxp3 loss has been shown to disrupt the
suppressive function of Tregs, reduce the expression of Tregs-
associated genes, and upregulate the expression of effector-type
cytokines, such INF-γ (39, 70). Conversely, knocking down
STUB1 stabilizes Foxp3 expression and increases the suppressive
potency of Tregs (39). Herein, we provide data indicating
that Tregs from the autoimmune-prone NOD mice have a
significantly lower ability to retain Foxp3 expression with respect
to Tregs from B6 and BALB/c mice. In addition, we report that
NOD Tregs have significantly higher STUB1/USP7 expression
ratios than B6 and BALB/c Tregs, suggesting that an unfavorable
balance in ubiquitination factors, together with an altered IL-
2R signaling, could be factors underlying the functional defects
shown by Tregs from NODmice.
Restoring the immune balance through the amplification
of Tregs represents a promising strategy to treat autoimmune
diseases. However, Foxp3+ Tregs might become unstable;
so, therapies combining the transfer of Tregs with Tregs-
stabilizing drugs are expected to be the most effective ones
to restrain autoimmune diseases. To select the appropriate
stabilizing drug, it is important to know the exact molecular
targets and cellular pathways that are particularly affected in
autoimmune prone individuals. Our results show the differential
expression of SOCS3, GRAIL, and STUB1/USP7 in Tregs from
the autoimmune-prone NOD mice, factors that may affect IL-
2R signaling and Foxp3 stability, resulting in insufficient and/or
defective Tregs to maintain self-tolerance. We envision that
these results may have significant implications for translational
research in human diseases.
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